Paeoniflorin attenuates hippocampal damage in a rat model of vascular dementia
- 27 October 2016
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 12 (6) , 3729-3734
Abstract
Paeoniflorn (PF), the principal bioactive component of Paeoniae radix prescribed in traditional Chinese medicine, possesses a wide range of biological effects and exhibits neuroprotective effects in numerous diseases. Previous studies have demonstrated that PF significantly attenuates memory impairment in rats with vascular dementia (VD). In the present study, a bilateral common carotid artery occlusion (BCCAO) rat model was used to explore the underlying mechanisms of PF. The expression levels of neuron‑specific enolase (NSE), S100β, B‑cell lymphoma 2 (Bcl‑2), Bcl‑2 associated X protein, cytochrome c and brain‑derived neurotrophic factor (BDNF) in the hippocampus were measured by western blot analysis. The results showed that administration of PF for 28 days significantly decreased the expression levels of NSE and S100β, both sensitive markers for brain damage, in vascular dementia (VD) model rats. In addition, PF inhibited the initiation of apoptotic cell death and attenuated the decreased expression levels of BDNF induced by bilateral common carotid artery occlusion. These data confirm the neuroprotective effects of PF on VD and provide a novel insight into the long‑term use of PF as a potential treatment in the stages of early cognitive impairment in VD.Keywords
This publication has 31 references indexed in Scilit:
- Protective Effects of p38 MAPK Inhibitor SB202190 against Hippocampal Apoptosis and Spatial Learning and Memory Deficits in a Rat Model of Vascular DementiaBioMed Research International, 2013
- Down-regulation of IGF-1/IGF-1R in hippocampus of rats with vascular dementiaNeuroscience Letters, 2012
- Vascular Risk Factors and Dementia: 40-Year Follow-Up of a Population-Based CohortDementia and Geriatric Cognitive Disorders, 2011
- Vascular Cognitive Impairment: Disease Mechanisms and Therapeutic ImplicationsNeurotherapeutics, 2011
- Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatmentActa Pharmacologica Sinica, 2009
- Oxidative Stress in Vascular Dementia and Alzheimer's Disease: A Common PathologyJournal of Alzheimer’s Disease, 2008
- The enigma of vascular cognitive disorder and vascular dementiaActa Neuropathologica, 2007
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Study of the oxidative stress in a rat model of chronic brain hypoperfusionNeurochemistry International, 2005
- Donepezil for vascular cognitive impairmentCochrane Database of Systematic Reviews, 2004